-
Jun 12, 2026Why NHP Molecular Imaging Is Critical For Translational PET StudiesDiscover why non-human primates are essential for translational molecular imaging, PET tracer development, CNS drug research, and radiopharmaceutical evaluation. -
Jun 10, 2026What Is Molecular Imaging And Why Is It Important in Drug Development?Learn how molecular imaging enables non-invasive visualization of biological processes in vivo and supports translational drug development through longitudinal assessment and bi... -
Jun 05, 2026NHP Radionuclide Biodistribution Studies: Molecular Imaging For Translational...Explore how PET-CT, SPECT, and radionuclide molecular imaging in non-human primates (NHPs) are advancing biodistribution, target engagement, and translational evaluation of anti... -
Jun 02, 2026NHP Heart Failure Model Supports Translational Research On Telomere Restorati...Learn how Prisys Biotechnologies' non-human primate heart failure model contributed to a landmark eBioMedicine study validating telomere restoration gene therapy and advancing c... -
May 29, 2026How DSA And CTA Imaging Improve Cardiovascular Drug Safety EvaluationExplore how DSA and CTA imaging technologies support cardiovascular drug safety evaluation, interventional research, and translational preclinical studies. -
May 27, 2026NHP Arteriovenous Shunt Thrombosis Model in Cynomolgus Monkeys For Translatio...Explore Prisys Biotechnologies’ cynomolgus monkey AV shunt thrombosis model for translational evaluation of anticoagulants, FXI inhibitors, and bleeding risk. -
May 15, 2026Non-Human Primate Models Of Pulmonary Fibrosis: Advancing Translational Accur...Explore advanced NHP models for pulmonary fibrosis. Prisys Biotech offers quantitative CT imaging, bronchoscopy-guided dosing, and clinical-grade lung function analysis for biop... -
May 14, 2026Why Drug Development Is Increasingly Dependent On NHP Models | Prisys BiotechDiscover why non-human primate (NHP) models are becoming essential in modern drug development. Learn how NHP pharmacology improves translational research, CNS studies, biologics... -
May 09, 2026PK Data As A Pharmacodynamic Biomarker: Advancing Translational Drug Developm...Discover how pharmacokinetic (PK) data functions as a pharmacodynamic biomarker in modern drug development. Learn how Prisys Biotech supports translational PK/PD research throug... -
Apr 17, 2026NHP AV-Shunt Thrombosis Model For Drug Safety Evaluation | Prisys BiotechExplore how Prisys Biotech uses NHP AV-shunt thrombosis and bleeding models to evaluate efficacy and bleeding risk of novel antibody therapeutics targeting coagulation pathways. -
Apr 14, 2026What Is Nonlinear Pharmacokinetics? Mechanisms And Translational PK Evaluatio...Learn what nonlinear pharmacokinetics is, its mechanisms, and why it matters in drug development. Discover how Prisys Biotech evaluates nonlinear PK using NHP models, PK/PD anal... -
Apr 10, 2026Prisys Biotech Supports IND Approval Of UX-GIP001 By FDA And CDE | NHP CNS De...UX-GIP001, an iPSC-derived cell therapy by UniXell Biotechnology, receives IND approvals from FDA and CDE. Prisys Biotech supports CNS delivery using NHP models and MRI-guided C...
